Бесплатная главастраницы PDF 15–34

Понимание диабетической ретинопатии и её зрительных последствий

В оригинале: Understanding Diabetic Retinopathy and Its Visual Implications

Из книги «Диагностика и лечение диабетической ретинопатии». Перевод главы на русский открыт всем без входа и подписки.

Содержание главы
  1. Глава 1. Диабетическая ретинопатия и её последствия для зрения
  2. Типы диабета
  3. Эпидемиология сахарного диабета и диабетической ретинопатии
  4. Патогенез диабетической ретинопатии
  5. Субклинические / доклинические изменения при диабетической ретинопатии
  6. Усиление полиолового пути
  7. Гексозаминовый путь
  8. Усиление образования AGE
  9. Усиление активации PKC
  10. Клинические стадии диабетической ретинопатии
  11. Непролиферативная диабетическая ретинопатия
  12. 1) Закрытие сосудов
  13. Микроаневризма
  14. 2) Патологическая проницаемость сосудов
  15. Твёрдые экссудаты
  16. Диабетическая макулопатия
  17. Пролиферативная диабетическая ретинопатия
  18. Осложнения пролиферативной диабетической ретинопатии
  19. Классификация диабетической ретинопатии
  20. Основы лечения
  21. Возможные осложнения лазерного лечения
  22. Заключение
  23. Литература
  1. 8. Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complication in Patients with Type 2 Diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
  2. 9. American Academy of Ophthalmology Retina Panel. Diabetic Retinopathy, 2003. www.guideline.gov/summary/summary.aspx?doc_id=4350 - 33k-
  3. 10. Rowe S, MacLean CH, Shekelle PG. Preventing Visual Loss from Chronic Eye Disease in Primary Care. JAMA 2004;291:1487-95.
  4. 11. Klein R, Klein BE, Moss SE Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XIV: Ten-year Incidence and Progression of Diabetic Retinopathy. Arch Ophthalmol 1994;112:1217-28.
  5. 12. van Leiden HA, Dekker JM, Moll AC et al. Risk Factors for Incident Retinopathy in a Diabetic and Non-diabetic Population: the Hoorn Study. Arch Ophthalmol 2003;121:245-51.
  6. 13. Zhang L, Krezntowski G, Albert A. Risk of Developing Retinopathy in Diabetes Control and Complications Trial type 1 Diabetic Patients with Good or Poor Metabolic Control. Diabetes Care 2001;24:1275-9.
  7. 14. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes Mellitus. JAMA 2002;287:2563-9.
  8. 15. Stratton IM, Kohner EE, Aldington SJ et al. UKPDS 50: Risk Factors for Incidence and Progression of Retinopathy in Type II Diabetes Over 6 Years from Diagnosis Diabetologia 2001;44:156-163.
  9. 16. Lyons TJ, Jenkins A, Zheng D. Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort. Invest Ophthalmol. Vis.Sci. 2004;45: 910-18.
  10. 17. Ucgun NI, Yildimir Z, Kilic N et al. The Importance of Serum Lipids in Exudative Diabetic Macular Edema in Type 2 Diabetic Patients. Ann.N.Y.Acad.Sci 2007;1100:213-7.
  11. 18. Miljanovic B, Glynn R, Nathan DM. A Prospective Study of Serum Lipids and Risk of Diabetic Macular Edema in Type 1 Diabetes. Diabetes 2004;53(11): 2883-92.
  12. 19. Ballone E, Cologrande V, Di Nicola M et al. Probabilistic Approach to Developing Nephropathy in Diabetic Patients with Retinopathy. Stat Med 2003;22:3889-97.
  13. 20. Romero AP, Salvat S, Mendez M. Is Microalbuminuria a Risk Factor for Diabetic Retinopathy? J. Fr. Opthalmology 2003;26:680-84.
  14. 21. Klein BE, Moss SE, Klein R. Effect of Pregnancy on Progression of Diabetic Retinopathy. Diabetes Care 1990;13:34-40.
  15. 22. Rahman W, Rahman RF, Yassin S et al. Progression of Retinopathy During Pregnancy in Type 1 Diabetes Mellitus. Clinical Experiment. Opthalmol. 2007;352:231-6.
  16. 23. Kumaramananickvel G, Sripriya S, Ramprasad VL, et al. Z-2 Aldose Reductase Allele and Diabetic Retinopathy in India. Ophthalmic Genet 2003;24:41-48.
  17. 24. Gardner TW. The Clinical Significance of Molecular Mechanisms Leading to Diabetic Microvascular Complications: Diabetic Retinopathy Is a Neurovascular Disorder. Medscape Internal Medicine 2003 16 June Pathways Leading to Diabetic Microvascular Complications and the Latest Clinical Therapies. 2003. New Orleans, Louisiana.
  18. 25. Balasubramanyam M, Rema M, Premanand C. Biochemical and Molecular Mechanisms of Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales. Current Science 2002; 83 (12, 25):1506-14.
  19. 26. Newman EA, Zahs K. Modulation of Neuronal Activity by Glial Cells in the Retina. The Journal of Neuroscience 1998;18 (11):4022-8.
  20. 27. Petropoulos IK, Margaritis PI, Antonelou MH. Structural Alterations of the Erythrocyte Membrane Proteins in Diabetic Retinopathy. Graefes Archive for Clinical & Experimental Ophthalmology. 2007; 245(8):1179-88.